UGC CARE norms ugc approved journal norms IJRTI Research Journal

Click Here

International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.14

Issue per Year : 12

Volume Published : 7

Issue Published : 77

Article Submitted : 4915

Article Published : 2787

Total Authors : 7177

Total Reviewer : 539

Total Countries : 57

Indexing Partner


This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Authors Name: Shaik Masthanisahiba
Download E-Certificate: Download
Author Reg. ID:
Published Paper Id: IJRTI2206039
Published In: Volume 7 Issue 6, June-2022
Abstract: Now a days , One of the most common type of cancer is breast cancer which can be mostly seen high natality rate in women worldwide. There are many types of treatment option for most cancers i.e., surgery , chemotherapy and radiology but most efficient and effective treatment is done by using nanotechnology. The centre of attention in this review is on various nanoparticles such as liposomes , polymeric nanoparticles , solid lipid nanoparticles as well as their applications in the treatment of breast cancer.In recent studies nanotechnology has been developed and having advance methods have been applied for the treatment various types of cancer. Currently this nanotechnology plays a vital role in the targeted drug delivery for the treatment of cancer. This nanoparticles mostly plays on tumors and involves the sustained release of drug to precise on particular sites so far it will improves the therapeutic efficiency of the relevant drug and decreases the toxicity in the particular site of tissues or organs and turn them into normal condition by ctivate the immune cells against the tumours. So these nanoparticles are promising advance tool for the cancer research & treatment . Key words : Breast cancer - Anti cancer drugs – Nanoparticles - Drug delivery – Advance method-Immune cells.
Cite Article: "NANOTECHNOLOGY : MODERN ADVANCES FOR THE DELIVERY OF ANTI-CANCER DRUGS IN THE TREATMENT OF BREAST CANCER", International Journal of Science & Engineering Development Research (, ISSN:2455-2631, Vol.7, Issue 6, page no.221 - 227, June-2022, Available :
Downloads: 000143968
ISSN: 2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID: IJRTI2206039
Registration ID:182287
Published In: Volume 7 Issue 6, June-2022
DOI (Digital Object Identifier):
Page No: 221 - 227
Country: Koduru, Andhra Pradesh, India
Research Area: Life Sciences 
Publisher : IJ Publication
Published Paper URL :
Published Paper PDF:
Share Article:

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager : cornell university library Research Gate CiteSeerX DOAJ : Directory of Open Access Journals
DRJI Index Copernicus International Scribd DocStoc

ISSN Details

ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)

Providing A digital object identifier by DOI.ONE
How to Get DOI?


Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Social Media

Join RMS/Earn 300


Indexing Partner